A Study to Assess the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Administered Intravenously (IV) as a Single Agent or in Combination With Chemotherapy in Chinese Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02825940 · COMPLETED
Trial details
- NCT number
- NCT02825940
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-04
- Primary completion
- 2020-01-14
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.